Lacktman Quoted on Proposed Registration Process for Telemedicine Prescriptions

21 November 2019 mHealth Intelligence News
Partner Nate Lacktman was quoted in an mHealth Intelligence article, “DEA Launches Registration Process for Prescriptions by Telemedicine,” about a long-awaited Justice Department proposal to create a special registration process that would allow health care providers to use telemedicine to prescribe controlled substances.

Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team, has long called for such a move, the article pointed out, quoting from a blog post he co-authored in 2018 in which he said that existing regulations “fail to account for how legitimate telemedicine services are delivered today.”
 

Related Services

Insights

Bad Holiday Season News! Estimates of an increase of Cyberattacks 20%!
13 December 2019
Internet, IT & e-Discovery Blog
Driving the Future of Automotive Technology
12 December 2019
Manufacturing Industry Advisor
Massachusetts Governor Proposes Facility Fee Ban
12 December 2019
Health Care Law Today
American Rule Prevails; PTO May Not Collect In-House Attorneys' Fees as "Expenses"
12 December 2019
IP Litigation Current
ACCC 46th Annual Meeting & Cancer Center Business Summit
04-05 March 2020
Washington, D.C.
Foley/Deloitte Compliance and Privacy Officer Roundtable
27 February 2020
Boston, MA
Let’s Talk Compliance
24 January 2020
Orlando, FL
New England Alliance Annual Meeting
15-17 January 2020
Woodstock, VT